Integra LifeSciences Holdings Corporation (IART)

IART · BiotechSign Pipeline

Pipeline Overview

Therapeutic Focus: Biotech / Pharmasrc

Signal Snapshot

Clinical Trials (ClinicalTrials.gov aggregate)

Catalyst Records

Publication on Record

ClinicalTrials.gov aggregate as of 2026-09-29. Source

Recent Publications

Thirty-day outcomes following transcarotid artery revascularization with integrated embolic protection: The PERFORMANCE III study. — J Vasc Surg (2026) PMID 42203082

Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Integra LifeSciences Holdings Corporation.

Full IART Data Sign Up Free

Primary Sources

Company identity
Therapeutic indication
Clinical trial aggregate
Publication 42203082

This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.